Thomas R. Webb

7.2k total citations
173 papers, 3.9k citations indexed

About

Thomas R. Webb is a scholar working on Molecular Biology, Organic Chemistry and Inorganic Chemistry. According to data from OpenAlex, Thomas R. Webb has authored 173 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Molecular Biology, 62 papers in Organic Chemistry and 18 papers in Inorganic Chemistry. Recurrent topics in Thomas R. Webb's work include Chemical Synthesis and Analysis (19 papers), RNA Research and Splicing (18 papers) and RNA and protein synthesis mechanisms (16 papers). Thomas R. Webb is often cited by papers focused on Chemical Synthesis and Analysis (19 papers), RNA Research and Splicing (18 papers) and RNA and protein synthesis mechanisms (16 papers). Thomas R. Webb collaborates with scholars based in United States, United Kingdom and Spain. Thomas R. Webb's co-authors include Chandraiah Lagisetti, Mark D. Matteucci, Philip M. Potter, F. Albert Cotton, Zerihun Assefa, G. E. Shankle, Howard H. Patterson, Mohammad A. Omary, Stephen W. White and Stephan W. Morris and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nucleic Acids Research.

In The Last Decade

Thomas R. Webb

149 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas R. Webb United States 36 1.9k 1.2k 542 414 282 173 3.9k
George L. Trainor United States 37 2.3k 1.2× 1.6k 1.4× 541 1.0× 170 0.4× 179 0.6× 83 4.5k
Christophe Dugave France 24 1.3k 0.7× 847 0.7× 247 0.5× 376 0.9× 293 1.0× 60 3.2k
M. J. Bennett United States 31 1.3k 0.7× 814 0.7× 310 0.6× 593 1.4× 83 0.3× 59 4.2k
E. T. Kaiser United States 45 6.9k 3.6× 2.7k 2.3× 960 1.8× 259 0.6× 136 0.5× 242 9.5k
Feng Yang China 38 2.5k 1.3× 1.1k 0.9× 1.9k 3.5× 443 1.1× 88 0.3× 132 4.8k
Yuko Aoki Japan 27 1.4k 0.7× 698 0.6× 700 1.3× 74 0.2× 314 1.1× 71 3.0k
David E. Ash United States 33 1.4k 0.7× 277 0.2× 328 0.6× 290 0.7× 157 0.6× 69 3.2k
William C. K. Pomerantz United States 33 1.9k 1.0× 790 0.7× 156 0.3× 86 0.2× 63 0.2× 99 2.9k
Y. Morimoto Japan 25 1.9k 1.0× 101 0.1× 316 0.6× 129 0.3× 171 0.6× 113 3.0k

Countries citing papers authored by Thomas R. Webb

Since Specialization
Citations

This map shows the geographic impact of Thomas R. Webb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas R. Webb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas R. Webb more than expected).

Fields of papers citing papers by Thomas R. Webb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas R. Webb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas R. Webb. The network helps show where Thomas R. Webb may publish in the future.

Co-authorship network of co-authors of Thomas R. Webb

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas R. Webb. A scholar is included among the top collaborators of Thomas R. Webb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas R. Webb. Thomas R. Webb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Gang, Liying Fan, Michael N. Edmonson, et al.. (2018). Inhibition of SF3B1 by molecules targeting the spliceosome results in massive aberrant exon skipping. RNA. 24(8). 1056–1066. 31 indexed citations
2.
Vigevani, Luisa, André Gohr, Thomas R. Webb, Manuel Irimia, & Juan Valcárcel. (2017). Molecular basis of differential 3′ splice site sensitivity to anti-tumor drugs targeting U2 snRNP. Nature Communications. 8(1). 2100–2100. 43 indexed citations
3.
Sharma, Lalit, et al.. (2014). Design and synthesis of molecular probes for the determination of the target of the anthelmintic drug praziquantel. Bioorganic & Medicinal Chemistry Letters. 24(11). 2469–2472. 9 indexed citations
4.
Kasinathan, Ravi S., Lalit Sharma, Charles Cunningham, Thomas R. Webb, & Robert M. Greenberg. (2014). Inhibition or Knockdown of ABC Transporters Enhances Susceptibility of Adult and Juvenile Schistosomes to Praziquantel. PLoS neglected tropical diseases. 8(10). e3265–e3265. 47 indexed citations
5.
Convertini, Paolo, Manli Shen, Philip M. Potter, et al.. (2014). Sudemycin E influences alternative splicing and changes chromatin modifications. Nucleic Acids Research. 42(8). 4947–4961. 58 indexed citations
6.
Hubert, Christopher G., Robert K. Bradley, Yu Ding, et al.. (2013). Genome-wide RNAi screens in human brain tumor isolates reveal a novel viability requirement for PHF5A. Genes & Development. 27(9). 1032–1045. 88 indexed citations
7.
Webb, Thomas R., et al.. (2012). The development and application of small molecule modulators of SF3b as therapeutic agents for cancer. Drug Discovery Today. 18(1-2). 43–49. 82 indexed citations
8.
Webb, Thomas R., Rani E. George, A. Thomas Look, et al.. (2009). Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy. Expert Review of Anticancer Therapy. 9(3). 331–356. 183 indexed citations
9.
Lee, Ju‐Yeon, et al.. (2009). Combinatorial synthesis and biological evaluation of peptide-binding GPCR-targeted library. Bioorganic Chemistry. 37(3). 90–95. 9 indexed citations
10.
Zhu, Tong, Zheng Yan, Alexander Chucholowski, Thomas R. Webb, & Rongshi Li. (2006). Polymer-Supported Synthesis of Pyridone-Focused Libraries as Inhibitors of Anaplastic Lymphoma Kinase. Journal of Combinatorial Chemistry. 8(3). 401–409. 3 indexed citations
11.
Huang, Charles Q., Dimitri E. Grigoriadis, Zhengyu Liu, et al.. (2004). Design, synthesis, and SAR of 2-dialkylamino-4-arylpyrimidines as potent and selective corticotropin-releasing factor 1 (CRF 1 ) receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 14(9). 2083–2086. 8 indexed citations
12.
Warheit, David B., Thomas R. Webb, Kenneth L. Reed, John F. Hansen, & Gerald L. Kennedy. (2003). Four-week inhalation toxicity study in rats with nylon respirable fibers: rapid lung clearance. Toxicology. 192(2-3). 189–210. 18 indexed citations
13.
Huang, Charles Q., Keith Wilcoxen, James R. McCarthy, et al.. (2003). Synthesis and SAR of 8-Arylquinolines as potent corticotropin-Releasing factor1 (CRF1) receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 13(19). 3375–3379. 20 indexed citations
14.
Kim, Yong‐Chul, et al.. (2003). Application of a novel design paradigm to generate general nonpeptide combinatorial scaffolds mimicking beta turns: synthesis of ligands for somatostatin receptors. Bioorganic & Medicinal Chemistry. 11(23). 5059–5068. 20 indexed citations
15.
Webb, Thomas R., et al.. (2003). Quinazolines as adenosine receptor antagonists: SAR and selectivity for A2B receptors. Bioorganic & Medicinal Chemistry. 11(1). 77–85. 29 indexed citations
16.
Warheit, David B., K. L. Reed, Kent E. Pinkerton, & Thomas R. Webb. (2002). Biodegradability of inhaled p-aramid respirable fiber-shaped particulates (RFP): mechanisms of RFP shortening and evidence of reversibility of pulmonary lesions. Toxicology Letters. 127(1-3). 259–267. 3 indexed citations
17.
Warheit, David B., Mark A. Hartsky, & Thomas R. Webb. (2000). Biodegradability of inhaled p-aramid respirable fibre-shaped particulates: Representative of other synthetic organic fibre-types?. International Archives of Occupational and Environmental Health. 73(S1). S75–S78. 5 indexed citations
18.
Webb, Thomas R., et al.. (2000). The utilization of a unified pharmacophore query in the discovery of new antagonists of the adenosine receptor family. Bioorganic & Medicinal Chemistry Letters. 10(1). 31–34. 21 indexed citations
19.
Smith, Robert C., et al.. (1993). Reversal of copper(II)-induced methemoglobin formation by thiols. Journal of Inorganic Biochemistry. 52(3). 173–182. 6 indexed citations
20.
Webb, Thomas R., Hiroaki Mitsuya, & Samuel Broder. (1988). 1-(2,3-Anhydro-.beta.-D-lyxofuranosyl)cytosine derivatives as potential inhibitors of the human immunodeficiency virus. Journal of Medicinal Chemistry. 31(7). 1475–1479. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by George L. Trainor Breakdown of academic impact, for papers by Christophe Dugave Breakdown of academic impact, for papers by M. J. Bennett Breakdown of academic impact, for papers by E. T. Kaiser Breakdown of academic impact, for papers by Feng Yang Breakdown of academic impact, for papers by Yuko Aoki Breakdown of academic impact, for papers by David E. Ash Breakdown of academic impact, for papers by William C. K. Pomerantz Breakdown of academic impact, for papers by Y. Morimoto
Rankless by CCL
2026